A modeling study quantifies the health-economic burden of Lassa virus infection across West Africa and projects impacts of a series of reactive and preventive vaccination campaigns against the disease, presenting substantial impacts in terms of averted disability-adjusted life years and healthcare cost reductions.
- David R. M. Smith
- Joanne Turner
- T. Déirdre Hollingsworth
